Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndrome

Introduction: The neonate exposed to opioids in utero faces a constellation of withdrawal symptoms postpartum commonly called neonatal opioid withdrawal syndrome (NOWS). The incidence of NOWS has increased in recent years due to the opioid epidemic. MicroRNAs (miRNAs) are small non-coding RNA molecu...

Descripción completa

Detalles Bibliográficos
Autores principales: Radhakrishna, Uppala, Nath, Swapan K., Uppala, Lavanya V., Veerappa, Avinash, Forray, Ariadna, Muvvala, Srinivas B., Metpally, Raghu P., Crist, Richard C., Berrettini, Wade H., Mausi, Lori M., Vishweswaraiah, Sangeetha, Bahado-Singh, Ray O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332887/
https://www.ncbi.nlm.nih.gov/pubmed/37434949
http://dx.doi.org/10.3389/fgene.2023.1215472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332887/
https://www.ncbi.nlm.nih.gov/pubmed/37434949
http://dx.doi.org/10.3389/fgene.2023.1215472

Ejemplares similares